Gerresheimer receives German Packaging Award 2011 for multilayer plastic vials for liquid medications, features multilayer composite of Cyclic Olefine Polymer, polyamide for increased oxygen barrier, leakage prevention

DUSSELDORF and NUREMBERG, Germany , November 10, 2011 (press release) – Gerresheimer’s new multilayer plastic vials unite the best properties of plastic and glass in a new high quality packaging for liquid medications. Now Gerresheimer has received the German Packaging Award 2011 in the Retail Packaging category for developing these vials which offer previously unattained levels of safety for parenteral drugs.

The German Packaging Award was launched in 1963 and is under the patronage of the Federal Ministry of Economics and Technology. German Packaging Award winners are automatically nominated for the World Packaging Organization’s (WPO) WorldStar packaging award. In a two-day selection process, the jury selected 54 candidates from a total of 237 valid entries. The awards were presented to the winners at a gala event in Nuremberg on November 9, 2011.

Parenteral medications are sterile preparations for administration to humans or animals by injection or infusion which can attack glass surfaces and cause glass particle contamination. This is the reason why packaging components are coming to play an increasingly important role in the development of drug delivery concepts for the new generation of biotech drugs. They have considerable influence on the stability and safety of medications which are generally marketed as parenteral solutions.

The new multilayer vials have a unique triple-layer structure consisting of a layer of polyamide sandwiched between two COP (Cyclic Olefine Polymer) layers. COP is an ultra-pure polymer which has already proven to have excellent compatibility with biotechnologically manufactured pharmaceuticals that have complex molecular structures. The polyamide layer functions as an oxygen barrier, resulting in a 40 times reduction of oxygen transmission compared with conventional plastic type vials. The absence of heavy metal ions increases the stability of oxidation-sensitive solutions and an inert surface minimizes possible interactions. The vial’s incomparable stability is due to the extraordinary shock resistance of the triple-layer structure. It prevents leakage and therefore enhances safety, which is an important consideration when using cytotoxics.

Multilayer vials have far higher break resistance than glass vials and are therefore the ideal packaging for parenteral medications with a wide pH range. The multilayer composite of COP and polyamide even prevents leakage of the solution when the external COP layer is damaged. This significantly enhances safety in handling toxic pharmaceuticals, a feature that single layer plastic vials cannot offer.

The new multilayer vials were developed in line with the ISO standards, which means that standard rubber closures and flanged caps can be used. The materials used also fulfill the stringent requirements for biocompatibility and all pharmacopeia requirements for pharmaceutical packaging made of plastic.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.

Our Group realizes revenues of around one billion euros and has around 10,000 employees at 45 locations in Europe, North and South America and Asia. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.